Market Closed -
Nyse
04:00:01 2024-05-21 pm EDT
|
5-day change
|
1st Jan Change
|
31.72
USD
|
+2.79%
|
|
+2.79%
|
+3.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,254
|
8,245
|
7,071
|
6,545
|
7,512
|
7,838
|
-
|
-
|
Enterprise Value (EV)
1 |
14,366
|
13,251
|
12,304
|
11,535
|
12,134
|
12,708
|
12,932
|
13,120
|
P/E ratio
|
26.8
x
|
51.9
x
|
16.9
x
|
15.5
x
|
30.7
x
|
23.6
x
|
21.5
x
|
22
x
|
Yield
|
6.26%
|
7.38%
|
9.06%
|
9.59%
|
8.74%
|
8.45%
|
8.47%
|
8.52%
|
Capitalization / Revenue
|
11.7
x
|
11.1
x
|
7.76
x
|
8.91
x
|
9.27
x
|
9.51
x
|
8.91
x
|
8.74
x
|
EV / Revenue
|
18.2
x
|
17.9
x
|
13.5
x
|
15.7
x
|
15
x
|
15.4
x
|
14.7
x
|
14.6
x
|
EV / EBITDA
|
16.8
x
|
16.2
x
|
12.5
x
|
14.5
x
|
14.2
x
|
13.7
x
|
13.1
x
|
12.7
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.27
x
|
-
|
1.81
x
|
1.72
x
|
2.1
x
|
1.88
x
|
1.86
x
|
1.84
x
|
Nbr of stocks (in thousands)
|
218,502
|
227,004
|
238,974
|
234,183
|
244,994
|
247,099
|
-
|
-
|
Reference price
2 |
42.35
|
36.32
|
29.59
|
27.95
|
30.66
|
31.72
|
31.72
|
31.72
|
Announcement Date
|
2/5/20
|
2/4/21
|
2/2/22
|
2/2/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
791.2
|
740.8
|
910.7
|
734.2
|
810
|
823.8
|
880
|
896.9
|
EBITDA
1 |
856
|
820.2
|
985.9
|
793.3
|
853.2
|
930.3
|
989.6
|
1,032
|
EBIT
1 |
551.7
|
490.3
|
643.9
|
460.9
|
533.5
|
588.9
|
649.8
|
675.3
|
Operating Margin
|
69.74%
|
66.18%
|
70.7%
|
62.78%
|
65.87%
|
71.48%
|
73.85%
|
75.29%
|
Earnings before Tax (EBT)
1 |
343.8
|
162.3
|
416.1
|
436.1
|
255.6
|
355
|
352.3
|
399.6
|
Net income
1 |
341.1
|
159.3
|
416.7
|
426.9
|
242.2
|
336.4
|
381.6
|
406.8
|
Net margin
|
43.12%
|
21.51%
|
45.76%
|
58.15%
|
29.9%
|
40.84%
|
43.36%
|
45.35%
|
EPS
2 |
1.580
|
0.7000
|
1.750
|
1.800
|
1.000
|
1.342
|
1.479
|
1.444
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
2.650
|
2.680
|
2.680
|
2.680
|
2.680
|
2.680
|
2.687
|
2.702
|
Announcement Date
|
2/5/20
|
2/4/21
|
2/2/22
|
2/2/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
214.3
|
213.3
|
207.5
|
203.2
|
110.1
|
185.1
|
215
|
205.9
|
204
|
203.2
|
204.4
|
209.5
|
213.9
|
215.6
|
217.6
|
EBITDA
1 |
228.8
|
229.3
|
222.2
|
217
|
124.8
|
193.7
|
224.1
|
217.9
|
217.6
|
218
|
226.9
|
230.9
|
235.4
|
242.1
|
245
|
EBIT
1 |
143.5
|
146.6
|
139
|
134.3
|
41.11
|
75.58
|
142.1
|
137.1
|
141.9
|
143.4
|
149
|
147.9
|
150.2
|
156.7
|
157.3
|
Operating Margin
|
66.97%
|
68.7%
|
66.95%
|
66.09%
|
37.32%
|
40.83%
|
66.08%
|
66.56%
|
69.56%
|
70.58%
|
72.89%
|
70.58%
|
70.22%
|
72.71%
|
72.29%
|
Earnings before Tax (EBT)
1 |
33.71
|
194.8
|
91.25
|
102.1
|
47.99
|
34.72
|
62.08
|
97.01
|
61.82
|
71.83
|
84.52
|
88.58
|
89.38
|
90
|
94.49
|
Net income
1 |
33.29
|
189.6
|
89.47
|
102.3
|
45.58
|
35.94
|
59.86
|
91.38
|
55
|
67.36
|
85.71
|
89.77
|
91.51
|
92.12
|
92.74
|
Net margin
|
15.53%
|
88.87%
|
43.11%
|
50.33%
|
41.38%
|
19.42%
|
27.84%
|
44.38%
|
26.96%
|
33.15%
|
41.93%
|
42.85%
|
42.78%
|
42.73%
|
42.61%
|
EPS
2 |
0.1400
|
0.7900
|
0.3800
|
0.4300
|
0.1900
|
0.1500
|
0.2500
|
0.3700
|
0.2200
|
0.2700
|
0.3467
|
0.3517
|
0.3583
|
0.3479
|
0.3498
|
Dividend per Share
2 |
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
-
|
0.6700
|
0.6700
|
0.6700
|
0.6734
|
0.6734
|
Announcement Date
|
2/2/22
|
5/2/22
|
8/1/22
|
11/2/22
|
2/2/23
|
5/2/23
|
8/2/23
|
11/2/23
|
2/7/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,112
|
5,006
|
5,233
|
4,990
|
4,623
|
4,871
|
5,094
|
5,282
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.972
x
|
6.103
x
|
5.308
x
|
6.289
x
|
5.418
x
|
5.235
x
|
5.148
x
|
5.117
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
10.3%
|
3.99%
|
10.8%
|
11.4%
|
6.74%
|
8.7%
|
10.3%
|
11.4%
|
ROA (Net income/ Total Assets)
|
4.25%
|
-
|
-
|
-
|
2.62%
|
3.23%
|
3.41%
|
3.58%
|
Assets
1 |
8,019
|
-
|
-
|
-
|
9,261
|
10,417
|
11,185
|
11,362
|
Book Value Per Share
2 |
18.60
|
-
|
16.30
|
16.20
|
14.60
|
16.80
|
17.00
|
17.30
|
Cash Flow per Share
2 |
-
|
-
|
2.960
|
2.560
|
-
|
2.840
|
3.010
|
3.130
|
Capex
1 |
-
|
-
|
-
|
-
|
-
|
11.9
|
12.5
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
1.44%
|
1.42%
|
-
|
Announcement Date
|
2/5/20
|
2/4/21
|
2/2/22
|
2/2/23
|
2/7/24
|
-
|
-
|
-
|
Last Close Price
31.72
USD Average target price
32.86
USD Spread / Average Target +3.58% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.46% | 7.84B | | +12.12% | 60.45B | | -2.95% | 19.54B | | -0.25% | 13.9B | | -7.31% | 6.05B | | +14.43% | 3.64B | | +0.84% | 3.33B | | +1.83% | 3B | | -6.05% | 3.09B | | +17.99% | 2.86B |
Healthcare REITs
|